Keeping Current
Experts discuss relevant and actionable strategies for practice improvement as well as timely clinical topics.
Optimizing Outcomes for Patients With IgAN: Novel B-Cell Targeted Therapies and the Changing Treatment Paradigm
Is your patient's proteinuria low enough? New KDIGO goals: target the immune cause and hit < />
Credit available for this activity expires: 12/2/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003055?ecd=bdc_podcast_libsyn_mscpedu
Advances in the Pharmacologic Management of Obesity: An Expert Digest of the Latest Data
Are you up to date on emerging pharmacologic therapies transforming obesity and type 2 diabetes care?
Credit available for this activity expires: 11/28/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/advances-pharmacologic-management-obesity-expert-digest-2025a1000v94
Breaking the Silence: Tackling Liver Fibrosis in MASH: Who to Treat With Novel Therapies
Do you know whom to treat and why? Learn about identifying and treating at-risk metabolic dysfunction-associated steatohepatitis (MASH).
Credit available for this activity expires: 11/25/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/breaking-silence-tackling-liver-fibrosis-mash-who-treat-2025a1000waj?ecd=bdc_podcast_libsyn_mscpedu
Coexisting Comorbidities: Advancing Holistic Care in COPD
Are you looking beyond the lung to provide holistic care for your patients with multimorbid chronic obstructive pulmonary disease (COPD)?
Credit available for this activity expires: 11/26/2025
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/coexisting-comorbidities-advancing-holistic-care-copd-2025a1000uiz?ecd=bdc_podcast_libsyn_mscpedu
Novel Biological Approaches for Enhanced Obesity and Diabetes Management – What's Next?
Hear from our panel of obesity and diabetes experts about emerging obesity and type 2 diabetes therapies addressing cardiovascular, hepatic, and metabolic complications.
Credit available for this activity expires: 11/25/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003022?ecd=bdc_podcast_libsyn_mscpedu
Latest Advances in mHSPC: An Update From Berlin 2025
Does the year 2025 mark a true, tangible shift toward biomarker-driven precision medicine for metastatic hormone-sensitive prostate cancer (mHSPC)?
Credit available for this activity expires: 11/18/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/latest-advances-mhspc-update-berlin-2025-2025a1000vlk?ecd=bdc_podcast_libsyn_mscpedu
Conference Insights: Breaking Developments in ALK-Positive NSCLC and ES-SCLC
Are you staying up to date on the latest practice-changing data revolutionizing the treatment for lung cancer?
Credit available for this activity expires: 11/18/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/conference-insights-breaking-developments-alk-positive-nsclc-2025a1000vwn?ecd=bdc_podcast_libsyn_mscpedu
Charting the Course for Metastatic Breast Cancer Care: Optimizing First-Line Treatment and Beyond
ADCs as first-line treatment? ESR1 monitoring before progression? Local therapy for CNS disease? Experts tackle today's toughest decisions.
Credit available for this activity expires: 11/14/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/charting-course-metastatic-breast-cancer-care-optimizing-2025a1000v4s?ecd=bdc_podcast_libsyn_mscpedu
Paving the Way for Success in Integrating Biosimilars Into Multiple Sclerosis Care: Optimizing Communication
Do you know what words patients do not want to hear?
Credit available for this activity expires: 11/13/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/paving-way-success-integrating-biosimilars-multiple-2025a1000v8w?ecd=bdc_podcast_libsyn_mscpedu
Advancing Personalized Care for Prostate Cancer: Patient-Centered Solutions for mHSPC and nmCRPC
What do patients really think about prostate cancer care? Is it true that 50% of men are still being undertreated?
Credit available for this activity expires: 11/12/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/advancing-personalized-care-prostate-cancer-patient-centered-2025a1000uyb?ecd=bdc_podcast_libsyn_mscpedu
Reshaping Obesity and Diabetes Care With Innovative Multiagonism Concepts
Hear about the promise of combination therapies and dual and triple agonists in helping people with obesity lose weight and improve overall health.
Credit available for this activity expires: 11/11/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003041?ecd=bdc_podcast_libsyn_mscpedu
The Hidden Battle: Understanding Chronic Inflammation in Aging People Living With HIV and Comorbidities
Untangle the hidden links between chronic inflammation, aging, HIV, and comorbidities.
Credit available for this activity expires: 11/5/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003078?ecd=bdc_podcast_libsyn_mscpedu
Emerging Therapies for MASH: From Theory to Clinical Practice
How much do you know about new therapies for treating fibrosis in MASH and the patients who can benefit most from them?
Credit available for this activity expires: 10/29/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003068?ecd=bdc_podcast_libsyn_mscpedu
Interpreting JC Virus Test Results in Multiple Sclerosis Management: Are You Up to Speed?
What do expert recommendations say about John Cunningham (JC) virus testing when switching to a biosimilar?
Credit available for this activity expires: 10/31/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/interpreting-jc-virus-test-results-multiple-sclerosis-2025a1000qzm?ecd=bdc_podcast_libsyn_mscpedu
Targeting Diabesity From Multiple Angles: Future Prospects and Imminent Realities
Diabesity at the annual European diabetes meeting: What did you miss?
Credit available for this activity expires: 10/30/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003003?ecd=bdc_podcast_libsyn_mscpedu
Neovascular AMD: Optimizing Disease Control for Your Patients
When and how to use longer durability therapies in neovascular age-related macular degeneration (nAMD).
Credit available for this activity expires: 10/27/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002961?ecd=bdc_podcast_libsyn_mscpedu
The Hidden Hurdle: Practical Insights on Drug-Drug Interactions in Prostate Cancer Management
Did you know more patients with prostate cancer die from heart disease than cancer? Learn to master drug interactions to protect both outcomes here.
Credit available for this activity expires: 10/17/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003015?ecd=bdc_podcast_libsyn_mscpedu
Managing Diabetic Macular Edema in Clinical Practice
The experts discuss strategies, new-generation anti-vascular endothelial growth factors (VEGFs), and the evidence that supports their use.
Credit available for this activity expires: 9/30/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002951?ecd=bdc_podcast_libsyn_mscpedu
Shaping the Future: Expert Insights on Perioperative Immunotherapy for Gastric/GEJ Cancers
Are you aware that programmed cell death-ligand 1 (PD-L1) testing may not be needed to guide immunotherapy decisions in resectable gastric/gastroesophageal junction (GEJ) cancers?
Credit available for this activity expires: 9/22/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002919?ecd=bdc_podcast_libsyn_mscpedu
Thyroid Eye Disease: How to Use Targeted Immunotherapy in Clinical Practice
Are you up to date on new treatment options for thyroid eye disease?
Credit available for this activity expires: 9/17/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002870?ecd=bdc_podcast_libsyn_mscpedu
Thyroid Eye Disease: How to Use Targeted Immunotherapy in Clinical Practice
Are you up to date on new treatment options for thyroid eye disease?
Credit available for this activity expires: 9/17/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002870?ecd=bdc_podcast_libsyn_mscpedu
Immunopathogenesis of IgAN and the Evolving Treatment Landscape: A Focus on the B-Cell Pathway
Discover how emerging B-cell-targeted therapies are transforming the treatment landscape and outcomes for patients with IgA nephropathy (IgAN).
Credit available for this activity expires: 9/18/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002833?ecd=bdc_podcast_libsyn_mscpedu
Targeted Therapies for NSCLC: Where Are We Today?
Are you up to date with therapy strategies for ALK translocation and EGFR mutation–positive non-small cell lung cancer?
Credit available for this activity expires: 9/10/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002896?ecd=bdc_podcast_libsyn_mscpedu
Advances in the Pharmacologic Management of Obesity: Looking Ahead to EASD 2025
Do you know the latest in obesity management?
Credit available for this activity expires: 9/5/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002891?ecd=bdc_podcast_libsyn_mscpedu
Squamous Cell Anal Carcinoma: Bridging Current Practice and Future Horizons With Immunotherapy
Do you know where immunotherapy fits in the treatment paradigm of squamous cell anal carcinoma?
Credit available for this activity expires: 9/3/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002850?ecd=bdc_podcast_libsyn_mscpedu
Epilepsy Undertreatment and Overtreatment: How Can We Strike a Balance?
The power to change lives and save lives: expert advice on how to recognize where action needs to be taken and what to do.
Credit available for this activity expires: 9/2/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002731?ecd=bdc_podcast_libsyn_mscpedu
Illuminating the Path: New Insights in EGFR-Mutated Advanced NSCLC
Are you aware of the latest developments for treating EGFR mutation–positive advanced/metastatic NSCLC?
Credit available for this activity expires: 8/29/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002869?ecd=bdc_podcast_libsyn_mscpedu
Antibody-Drug Conjugates in Practice: Contemporary Questions for the Treatment of Metastatic Breast Cancer
Can you give patients one ADC after another? A renowned panel of experts interrogate this question and many more in this thought-provoking program.
Credit available for this activity expires: 8/25/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002851?ecd=bdc_podcast_libsyn_mscpedu
JC Virus Testing 101: What You Need to Know About JC Virus Testing in Multiple Sclerosis Care
Do you know how John Cunningham (JC) virus assays work?
Credit available for this activity expires: 8/22/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002825?ecd=bdc_podcast_libsyn_mscpedu
The Basis of Success: Recognizing IgAN and Promoting Earlier Diagnosis to Facilitate Treatment Initiation
IgA nephropathy is often diagnosed late. Recognizing and referring patients timely improves management and outcomes.
Credit available for this activity expires: 8/19/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002763?ecd=bdc_podcast_libsyn_mscpedu
Hormone Receptor-Positive Metastatic Breast Cancer: Novel Endocrine-Based Strategies and Options After Progression
Join here for expert analysis of the latest clinical trial data in HR-positive MBC and discussion of the clinical implications of these study results.
Credit available for this activity expires: 8/18/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002835?ecd=bdc_podcast_libsyn_mscpedu
Navigating Biomarker Conversations: Empowering Patient Understanding in Gastroesophageal Cancer
How confident are you navigating biomarker conversations with your gastric cancer patients?
Credit available for this activity expires: 8/19/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002840?ecd=bdc_podcast_libsyn_mscpedu
Long COVID in Context: A Closer Look at Post-Viral Syndrome and Management Approaches
Are you up to date on long COVID's impact, prevention, and management? Explore the latest evidence and expert perspectives here.
Credit available for this activity expires: 8/19/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002795?ecd=bdc_podcast_libsyn_mscpedu
Tumor-Like Masses, Abdominal Swelling, Pancreatic Involvement: Making Sense of IgG4-Related Disease, a Multiorgan Fibroinflammatory Condition
Immunoglobulin G4-related disease (IgG4-RD) isn't always obvious; join our expert roundtable to learn when to suspect it and how to detect flares.
Credit available for this activity expires: 8/12/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002730?ecd=bdc_podcast_libsyn_mscpedu
Monitoring ESR1 ctDNA During First-Line Care of HR-Positive Advanced Breast Cancer: A New Approach
When do you first test for ESR1 mutation in hormone receptor (HR)-positive advanced breast cancer (ABC)?
Credit available for this activity expires: 8/7/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002782?ecd=bdc_podcast_libsyn_mscpedu
ADA 2025 Highlights: The Weight of Evidence for Emerging Combination Therapies in Obesity and Diabetes Care
Stay up to date with the latest on combination therapies for weight reduction presented at ADA 2025.
Credit available for this activity expires: 7/28/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002750?ecd=bdc_podcast_libsyn_mscpedu
Advancing Treatment for HER2-Positive Advanced Breast Cancer: Expert Analysis of the Latest Developments
Join this program to get the latest commentary on updates in HER2-positive advanced and metastatic breast cancer.
Credit available for this activity expires: 7/29/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002765?ecd=bdc_podcast_libsyn_mscpedu
Personalized Pathways: Tailoring Care for Patients With Newly Diagnosed Multiple Myeloma
How familiar are you with the latest strategies to individualize treatment for patients with newly diagnosed multiple myeloma (NDMM)?
Credit available for this activity expires: 7/25/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002741?ecd=bdc_podcast_libsyn_mscpedu
Quickfire Updates on Gastric/GEJ Cancers: Latest Data in Perioperative Immunotherapy
Is it time to rethink perioperative immunotherapy in resectable gastric and gastroesophageal junction (GEJ) cancers? See the latest data and expert takeaways.
Credit available for this activity expires: 7/18/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002710?ecd=bdc_podcast_libsyn_mscpedu
IgG-Mediated Autoimmune Disorders: A Clinical Update on Novel Therapies Targeting FcRn
New therapies for myositis and Sjögren disease: are you up to date?
Credit available for this activity expires: 7/15/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002691?ecd=bdc_podcast_libsyn_mscpedu
